Mark A. Cantu

Ceftriaxone reduces <scp>L</scp>‐dopa–induced dyskinesia severity in 6‐hydroxydopamine parkinson's disease model

Tanya Chotibut, Samantha M. Meadows, Ella A. Kasanga et al. · Movement Disorders · 2017 · 53 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Tyrosine Hydroxylase Inhibition in Substantia Nigra Decreases Movement Frequency

Michael F. Salvatore, Tamara R. McInnis, Mark A. Cantu et al. · Molecular Neurobiology · 2018 · 41 citations

Medicine, Neurobiology, Pharmacology +13

Dissociation of Striatal Dopamine and Tyrosine Hydroxylase Expression from Aging-Related Motor Decline: Evidence from Calorie Restriction Intervention

Michael F. Salvatore, Jennifer Terrebonne, Mark A. Cantu et al. · The Journals of Gerontology Series A · 2017 · 35 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Effects of progesterone and norethindrone on female fathead minnow (<i>Pimephales promelas</i>) steroidogenesis

Lene H. Petersen, David Hala, Dennis R. Carty et al. · Environmental Toxicology and Chemistry · 2014 · 25 citations

Life Sciences, Endocrinology, Toxicology +13

Glatiramer Acetate Reverses Motor Dysfunction and the Decrease in Tyrosine Hydroxylase Levels in a Mouse Model of Parkinson's Disease

Madeline J. Churchill, Mark A. Cantu, Ella A. Kasanga et al. · Neuroscience · 2019 · 25 citations

Life Sciences, Neuroscience, Pharmacology +15